HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qun He Selected Research

Nephroureterectomy

6/2016The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy.
5/2015High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qun He Research Topics

Disease

33Neoplasms (Cancer)
01/2022 - 06/2002
17Carcinoma (Carcinomatosis)
01/2022 - 07/2006
11Leukemia
08/2013 - 08/2003
10Prostatic Neoplasms (Prostate Cancer)
01/2020 - 07/2006
9Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 10/2007
5Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
06/2022 - 10/2007
5Carcinogenesis
01/2022 - 01/2004
5Inflammation (Inflammations)
01/2019 - 01/2007
3Renal Cell Carcinoma (Grawitz Tumor)
08/2021 - 02/2012
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021 - 08/2011
3Neoplasm Metastasis (Metastasis)
01/2020 - 01/2016
3Hypertension (High Blood Pressure)
08/2011 - 07/2007
2Infections
01/2020 - 08/2013
2Lymphatic Metastasis
01/2020 - 08/2014
2Colitis
08/2019 - 01/2007
2Breast Neoplasms (Breast Cancer)
05/2016 - 01/2016
2Necrosis
01/2016 - 04/2002
2Adenocarcinoma
05/2013 - 08/2012
2Edema (Dropsy)
01/2012 - 01/2007
2Ganglion Cysts (Ganglion)
05/2008 - 07/2007
2Hyperplasia
07/2007 - 07/2006
1Fibrosis (Cirrhosis)
06/2022
1Microsatellite Instability
01/2022
1B-Cell Leukemia (Leukemia, B Cell)
01/2022
1Hereditary leiomyomatosis and renal cell cancer
11/2021
1Type 2 Diabetes Mellitus (MODY)
11/2021
1Astrocytoma (Pilocytic Astrocytoma)
04/2021
1Glioma (Gliomas)
04/2021
1Disease Progression
01/2021
1Critical Illness (Critically Ill)
12/2020
1Kidney Neoplasms (Kidney Cancer)
01/2020
1Sarcoma (Soft Tissue Sarcoma)
11/2019
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2019
1Herpes Zoster
08/2019
1Proteinuria
01/2019
1Inborn Genetic Diseases (Disease, Hereditary)
01/2019
1Polyps
01/2019
1Urinary Tract Infections (Urinary Tract Infection)
01/2019
1Hereditary Nephritis (Alport Syndrome)
01/2019

Drug/Important Bio-Agent (IBA)

10Biomarkers (Surrogate Marker)IBA
11/2021 - 05/2013
7Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2006
4RNA (Ribonucleic Acid)IBA
01/2022 - 02/2012
3DNA (Deoxyribonucleic Acid)IBA
04/2021 - 08/2003
3Cell-Free Nucleic AcidsIBA
01/2021 - 01/2020
3LigandsIBA
04/2020 - 05/2017
3Biological ProductsIBA
11/2019 - 08/2014
3Long Noncoding RNAIBA
02/2017 - 10/2015
2CollagenIBA
06/2022 - 01/2018
2Circular RNAIBA
01/2022 - 01/2021
2Aristolochic AcidsIBA
01/2020 - 11/2019
2aristolochic acid I (aristolochic acid)IBA
01/2020 - 01/2018
2ParaffinIBA
01/2019 - 01/2019
2Hematoxylin (Haematoxylon)IBA
01/2018 - 06/2002
2Eosine Yellowish-(YS) (Eosin)IBA
01/2018 - 06/2002
2Cadherins (E-Cadherin)IBA
05/2017 - 10/2015
2IronIBA
01/2017 - 07/2014
2Small Interfering RNA (siRNA)IBA
10/2015 - 05/2015
2AntigensIBA
01/2015 - 02/2012
2SmokeIBA
08/2014 - 01/2007
2Carrier Proteins (Binding Protein)IBA
10/2011 - 07/2006
2Messenger RNA (mRNA)IBA
08/2011 - 12/2005
2salicylhydroxamic acid (SHAM)IBA
05/2008 - 07/2007
2Lithium ChlorideIBA
12/2005 - 08/2003
1Estrogen ReceptorsIBA
06/2022
1Estrogens (Estrogen)FDA Link
06/2022
1GTP-Binding Proteins (G-Protein)IBA
06/2022
1sacituzumab govitecanIBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1enfortumab vedotinIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
11/2021
1Fumarate Hydratase (Fumarase)IBA
11/2021
1B7-H1 AntigenIBA
11/2021
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
08/2021
1Pharmaceutical PreparationsIBA
04/2021
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
04/2021
1Prostate-Specific Antigen (Semenogelase)IBA
01/2021
1CatalaseIBA
01/2020
1Imatinib Mesylate (Gleevec)FDA Link
01/2020
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
08/2019
1Dextrans (Dextran)FDA Link
08/2019
1OccludinIBA
08/2019
12,5-dichloro-4-bromophenol (B 2)IBA
08/2019
1Drinking WaterIBA
08/2019
1Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA
01/2019
1Collagen Type IV (Type IV Collagen)IBA
01/2019
1CytokinesIBA
01/2019
1Guanosine Monophosphate (5' Guanylic Acid)IBA
01/2019
1Polytetrafluoroethylene (Teflon)FDA Link
01/2019

Therapy/Procedure

10Therapeutics
01/2020 - 12/2006
8Cystectomy
01/2021 - 07/2006
4Prostatectomy (Retropubic Prostatectomy)
01/2020 - 02/2012
3Immunotherapy
04/2020 - 05/2017
2Punctures
12/2020 - 10/2007
2Transurethral Resection of Prostate (TURP)
01/2019 - 10/2007
2Operative Time
01/2019 - 08/2011
2Nephroureterectomy
06/2016 - 05/2015
2Lymph Node Excision (Lymph Node Dissection)
08/2014 - 08/2011
2Hematopoietic Stem Cell Transplantation
08/2013 - 06/2007
2Cystostomy (Suprapubic Cystostomy)
05/2008 - 07/2007
1Drug Therapy (Chemotherapy)
01/2019